Funding for this research was provided by:
National Natural Science Foundation of China (81774069, 81570614)
National Basic Research Program of China (973 Program) (2016YFC0906101)
Guangdong Science Foundation of China (2014B020212020, 2017A050503003, 2017B020227006)
Foundation of Guangdong Key Laboratory of Nephrology (2017B030314019)
Guangzhou Committee of Science and Technology, China (2014Y2-00543, 201704020167)
Science and Technology Planning Project of Guangdong Province of China (A2018353)
Received: 26 April 2018
Accepted: 3 June 2019
First Online: 2 July 2019
Ethics approval and consent to participate
: The study protocol was consistent with the ethical principles of the Helsinki Declaration and was approved by the Ethics Committee of The First Affiliated Hospital, Sun Yat-sen University. All participants were asked for permission to use their medical data for a non-commercial study, and written informed consent was obtained from them at the initiation of PD follow-up.
: Not applicable.
: The authors declare that they have no competing interests.